SCHEMBL20168001

SCHEMBL20168001

CC(C)(C#Cc1c(F)cccc1CN1CCNCC1C(=O)OC(C(F)(F)F)C(F)(F)F)C(=O)OCC[Si](C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 6/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20137024 0.80 MGLL (0.75) MGLL
SCHEMBL20168155 0.76 MGLL (0.48) MGLL
SCHEMBL29561159 0.73 MGLL (0.57) MGLL
SCHEMBL28712188 0.73 MGLL (0.49) MGLL
SCHEMBL15094550 0.73 MGLL (0.48) MGLL
SCHEMBL15094745 0.69 MAOB (0.40) MGLL
SCHEMBL15094594 0.68 ABHD6 (0.41) MGLL
SCHEMBL15094455 0.68 MGLL (0.46) MGLL
SCHEMBL15094740 0.68 FFAR4 (0.36) MGLL
SCHEMBL15095070 0.68 MGLL (0.49) MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3541821-A1 MAGL INHIBITORS Abide Therapeutics, Inc. (US) 2019-09-25 — — EP disclosed
WO-2018093947-A1 MAGL INHIBITORS ABIDE THERAPEUTICS, INC. (US) 2018-05-24 — — WO disclosed
Send feedback